Sort   by:  
 Page size 
UnknownChanges in Heart Rate Associated with Exenatide Once Weekly: Pooled Analysis of Clinical Data in Patients with Type 2 Diabetes.
Not available
S-EPMC6104267 | biostudies-literature
UnknownA Quality-adjusted Time Without Symptoms or Toxicity (Q-TWiST) Analysis of Nivolumab Versus Everolimus in Advanced Renal Cell Carcinoma (aRCC).
Not available
S-EPMC8262523 | biostudies-literature
UnknownUse of a Conformational-Switching Mechanism to Modulate Exposed Polarity: Discovery of CCR2 Antagonist BMS-741672.
Not available
S-EPMC6421546 | biostudies-literature
UnknownNivolumab plus Ipilimumab versus Sunitinib in Advanced Renal-Cell Carcinoma.
Not available
S-EPMC5972549 | biostudies-literature
UnknownDivergent Clonal Evolution and Early Dissemination Promote Genetic Heterogeneity of Metastases in Castration-Resistant Prostate Cancer.
Not available
S-EPMC12580794 | biostudies-literature
UnknownNivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma.
Not available
S-EPMC8436591 | biostudies-literature
UnknownA conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target.
Not available
S-EPMC7269585 | biostudies-literature
UnknownDevelopment of 4-Heteroarylamino-1'-azaspiro[oxazole-5,3'-bicyclo[2.2.2]octanes] as α7 Nicotinic Receptor Agonists.
Not available
S-EPMC5238485 | biostudies-literature
UnknownNivolumab for Metastatic Renal Cell Carcinoma: Results of a Randomized Phase II Trial.
Not available
S-EPMC4806782 | biostudies-literature
UnknownGPRC5D-Targeted CAR T Cells for Myeloma.
Not available
S-EPMC10309537 | biostudies-literature
Sort   by:  
 Page size